Emmes launches cell and gene therapy center
Emmes has announced the creation of a dedicated center for cell and gene therapy research: which will focus on supporting clinical trials for the Clinical Research Organization’s (CRO) clients.
Archives for December 8, 2022
The Native Antigen Company expands portfolio to support research into vaccines targeting Sudan Ebolavirus
A newly released antigen is aimed at bolstering immunoassay and vaccine development research focused on the Sudan Ebolavirus.
FDA expected to make decision on Pfizer RSV vaccine in May
The US Food and Drug Administration (FDA) has accepted Pfizer’s RSV vaccine Biologics License Application (BLA) for priority review: with a decision expected in May.